Poorly Differentiated Thyroid Cancer
1 clinical trials · Condition
◉ Watch Poorly Differentiated Thyroid Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting (NCT02041260) | Thomas Jefferson University | 2014-01-01 |
Track Poorly Differentiated Thyroid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.